Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
暂无分享,去创建一个
J. Schalken | H. Bloemendal | M. Smits | I. V. van Oort | N. Mehra | W. Gerritsen | L. Kroeze | K. Grünberg | M. Ligtenberg | P. Slootbeek | I. Kloots